Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab

National Cancer Institute (NCI) · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
cell-therapygene-therapyimmunotherapy
metastatic hpv-16 positive squamous cell anal cancer, gene therapy, immunotherapy, cell therapy, adoptive cell therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 968753
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.